Cargando…

COVID-19 in congenital heart disease patients: what did we learn?!

AIM: COVID-19 pandemic has spread widely at unpreceded pace. Cardiovascular comorbidities are significantly correlated with severe and critical illness. Nevertheless, studies examining the impact of congenital heart disease on COVID-19 severity are scarce and restricted to hospitalized patients. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zareef, Rana, Salameh, Elio, Hammoud, Rawan, Tannouri, Theresia, Bitar, Fadi, Arabi, Mariam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501459/ https://www.ncbi.nlm.nih.gov/pubmed/37719985 http://dx.doi.org/10.3389/fcvm.2023.1235165

Ejemplares similares

Pulmonary artery debanding in the cath lab: Lessons learned!
por: Zareef, Rana, et al.
Publicado: (2022)

COVID-19 in Pediatric Patients: A Focus on CHD Patients
por: Zareef, Rana O., et al.
Publicado: (2020)

Tamponade and massive pleural effusions secondary to peripherally inserted central catheter in neonates–A complication to be aware of
por: Zareef, Rana, et al.
Publicado: (2023)

Corticosteroids in COVID-19: pros and cons
por: Bahsoun, Aymen, et al.
Publicado: (2023)

Pathogenesis and distribution of infective endocarditis in the pediatric population: a 20-year experience in a tertiary care center in a developing country
por: Rashed, Moustafa, et al.
Publicado: (2023)

A Novel Mutation in FOXC1 in a Lebanese Family with Congenital Heart Disease and Anterior Segment Dysgenesis: Potential Roles for NFATC1 and DPT in the Phenotypic Variations
por: Khalil, Athar, et al.
Publicado: (2017)

Ivabradine: A Potential Therapeutic for Children With Refractory SVT
por: Younis, Nour K., et al.
Publicado: (2021)

COVID-19 in Cyanotic Congenital Heart Disease
por: Ammar, Lama A, et al.
Publicado: (2023)

Low molecular weight heparin in COVID-19: benefits and concerns
por: Makarem, Adham, et al.
Publicado: (2023)

COVID-19: potential therapeutics for pediatric patients
por: Younis, Nour K., et al.
Publicado: (2021)

Transcatheter Bioprosthetic Aortic Valve Dysfunction: What We Know So Far
por: Sawaya, Fadi, et al.
Publicado: (2019)

Aspirin in COVID-19: Pros and Cons
por: Zareef, Rana, et al.
Publicado: (2022)

Hydroxychloroquine in COVID-19 Patients: Pros and Cons
por: Younis, Nour K., et al.
Publicado: (2020)

Cardiac Manifestations in COVID-19 Patients: A Focus on the Pediatric Population
por: Abi Nassif, Tania, et al.
Publicado: (2021)

Congenital Heart Disease: An Immunological Perspective
por: Singampalli, Kavya L., et al.
Publicado: (2021)

Editorial: Aortopathy in congenital heart disease
por: Weismann, Constance G., et al.
Publicado: (2023)

Editorial: Myocardial fibrosis: What we know now
por: Kania, Gabriela, et al.
Publicado: (2023)

What else did we learn?
por: Pojer, M
Publicado: (2009)

What did we learn today?
por: Midtvedt, Tore
Publicado: (2015)

Heart-brain axis: Association of congenital heart abnormality and brain diseases
por: Sha, Leihao, et al.
Publicado: (2023)

Assessment of Diastolic Function in Congenital Heart Disease
por: Panesar, Dilveer Kaur, et al.
Publicado: (2017)

Noncardiac anomalies in children with congenital heart disease
por: Huang, Xianghui, et al.
Publicado: (2023)

The first Fetal Echocardiography experience for Prenatal diagnosis of Congenital Heart Disease in Lebanon: Successes and challenges
por: Charafeddine, Fatme, et al.
Publicado: (2019)

Chronic Thromboembolic Pulmonary Hypertension – What Have We Learned From Large Animal Models
por: Stam, Kelly, et al.
Publicado: (2021)

The “Right” Definition for Post–Left Ventricular Assist Device Right Heart Failure: The More We Learn, the Less We Know
por: Hall, Shelley A., et al.
Publicado: (2022)

Using Innovative Machine Learning Methods to Screen and Identify Predictors of Congenital Heart Diseases
por: Qu, Yanji, et al.
Publicado: (2022)

Heart Failure Risk Predictions and Prognostic Factors in Adults With Congenital Heart Diseases
por: Leczycki, Patryk, et al.
Publicado: (2022)

Impact of severe valvular heart disease in adult congenital heart disease patients
por: Graziani, Francesca, et al.
Publicado: (2022)

Myocardial Architecture, Mechanics, and Fibrosis in Congenital Heart Disease
por: Ghonim, Sarah, et al.
Publicado: (2017)

Accelerated Cardiac Aging in Patients With Congenital Heart Disease
por: Iacobazzi, Dominga, et al.
Publicado: (2022)

Congenital Heart Diseases and Periodontal Diseases—Is There a Link?
por: Rughwani, Roshan R., et al.
Publicado: (2022)

Race and Genetics in Congenital Heart Disease: Application of iPSCs, Omics, and Machine Learning Technologies
por: Mullen, McKay, et al.
Publicado: (2021)

Mitochondrial Respiration Defects in Single-Ventricle Congenital Heart Disease
por: Xu, Xinxiu, et al.
Publicado: (2021)

Corrigendum: Accelerated cardiac aging in patients with congenital heart disease
por: Iacobazzi, Dominga, et al.
Publicado: (2022)

Metabolomics and random forests in patients with complex congenital heart disease
por: Michel, Miriam, et al.
Publicado: (2022)

What did we learn in school today ?
por: Tröster, D A
Publicado: (1989)

What did we know? what did we do?: making decisions in large organizations
por: Herzner, Fred, et al.
Publicado: (2018)

Brugada Syndrome in Women: What Do We Know After 30 Years?
por: Martínez-Barrios, Estefanía, et al.
Publicado: (2022)

Prenatal Management Strategy for Immune-Associated Congenital Heart Block in Fetuses
por: Liao, Hongyu, et al.
Publicado: (2021)

Epidemiological Aspects, Prenatal Screening and Diagnosis of Congenital Heart Defects in Beijing
por: Zhang, Yanchun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l6pf97tfabhhcvva2qftr49395